Latest News & Updates
Breaking News
2 hours ago
Pharma Now Editorial Team
Exciva's SERENADA Trial Signals Shifting CNS Manufacturing Demands
Pharma Now Editorial Team
Tafamidis Generic Entry Pushed to 2031 After Pfizer Settlements
Pharma Now Editorial Team
Recalled Product Relaunch Drives Sanofi Consumer Healthcare's Q1 Surge
Pharma Now Editorial Team
Other trending news you may like to read
Miv-Cel Phase 2 Data Signal Manufacturing Readiness Pressure for CAR-T Makers
Miv-cel hits 46% median walk improvement in SPS phase 2, raising GMP readiness questions for autologous CAR-T manufacturers.
Pharma Now Editorial Team
Exciva's SERENADA Trial Signals Shifting CNS Manufacturing Demands
Exciva doses first SERENADA trial patient as EUR 53M Series B closes, raising CNS manufacturing and QA planning questions.
Pharma Now Editorial Team
Tafamidis Generic Entry Pushed to 2031 After Pfizer Settlements
Pfizer's Delaware patent settlements extend VYNDAMAX US exclusivity to June 2031, reshaping generic tafamidis entry timelines.
Pharma Now Editorial Team
The Future of Pharma Manufacturing Was Discussed in Amsterdam. Here's What Matters
PHARMAP 2026 in Amsterdam convenes senior pharma leaders on Pharma 4.0, smart manufacturing, supply chain resilience, and patient‑centric packaging innovation.
Team Pharma Now
